Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Red Blood Cell Transfusions for Sickle Cell Disease
source: St. Jude Children’s Research Hospital
year: N/A
summary/abstract:This type of procedure involves the transfer of red blood cells from one (1) person to another. Red blood cells are obtained when a person donates blood. The red cells are separated from the other parts of blood. These red blood cells are collected in a bag, stored in a refrigerator, and then given to another person through a vein. Donated blood cells are carefully tested for infections and closely matched to the recipient to prevent reactions.
Normal red blood cells carry oxygen throughout the body. The red blood cells of people with sickle cell disease do not deliver oxygen as well as normal red blood cells do.
In addition, these cells may change into a sickle shape, which blocks the flow of blood through the vessels. When a person with sickle cell disease has certain complications (health problems) from the disease, transfusing normal red blood cells may help deliver oxygen to the body and unblock blood vessels.
read more
Related Content
-
These patients had sickle-cell disease. Experimental therapies might have cured themScientists have long known what causes s...
-
Initial results from a cohort in a phase 2a study (GBT440-007) evaluating adolescents with sickle cell disease treat...Background: Sickle cell disease (SCD), ...
-
First systemic evidence for safety of tPA in stroke patients with sickle cell diseaseIn the largest report on acute stroke in...
-
GBT expands sickle cell disease pipeline with worldwide licensing agreement for inclacumab for the treatment of vaso...Global Blood Therapeutics, Inc...
-
Crizanlizumab lowers pain crises in at-risk sickle cell patients, ad-hoc trial data showNovartis’ investigational th...
-
Drugs for preventing red blood cell dehydration in people with sickle cell diseaseBackground:Sickle cell disease is an inh...
-
GBT announces positive top-line data from part A of the phase 3 HOPE study of Voxelotor in sickle cell diseaseGlobal Blood Therapeutics, Inc. today an...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
+myBinder